Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Levetiracetam as a Possible Cause of Fulminant Liver Failure
Neurol 71:685-686, Tan,T.C.H.,et al., 2008
Tiagabine-Induced Myoclonic Status Epilepticus in a Nonepileptic Patient
Neurol 68:310, Vollmar,C. &Noachtar,S., 2007
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999
Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Psychogenic Seizures:Ictal Characteristics and Diagnostic Pitfalls
Neurol 42:95-99, Leis,A.A.,et al, 1992
Valproate-Induced Coma with Ketosis and Carnitine Insufficiency
Arch Neurol 47:1131-1133, Triggs,W.J.,et al, 1990
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Coarse Facies, Calvarial Thickening & Hyperphosphatasia Associated with Long-Term Anticonvulsant Therapy
NEJM 286:1301, 1972; 287:721972., Lefebvre,E.,et al, 1972